A randomized, double-blind, placebo-controlled, Phase I/II trial of RNActive®-vaccine cv9104 in patients with metastatic castrate-refractory prostate cancer (mcrpc): first results of the Phase I part

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 3,706 followers.

@TonJeanne @les_vaxxeuses @Oliviersanstom @FrancoisBulloc1 https://t.co/qxO7CiLPCn ici cette étude dont 'la conclusion est positive renvoie à son protocole qui montre sur le site d' enregistrement de protocole une non publication. "aucun résultat publié" s

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.